Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world - Kapelios, Chris J.; Lainscak, Mitja; Savarese, Gianluigi; Laroche, Cécile; Seferovic, Petar; Ruschitzka, Frank; Coats, Andrew; Anker, Stefan D.; Crespo‐Leiro, Maria G.; Filippatos, Gerasimos; Piepoli, Massimo F.; Rosano, Giuseppe; et al. (European Journal of Heart Failure, 2019)